A new study identifies the E3 ubiquitin ligase HERC4 as the long-sought molecular switch that licenses RIPK1 to initiate ...

Distinct profiles between mild and severe COVID-19 patients reveal why some fight off infection easily while others don't, guiding the development of mutation-resistant vaccines.

First CNSide payer agreement to include CNSide’s new CSF Molecular Profile tests alongside tumor cell enumeration Expands CNSide contracted payer access to approximately 164 million covered lives ...

CellFiber, a biotechnology company specialising in cell and gene therapy technologies, has announced the official launch of ...

Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company specializing in defense, national security, and global markets, today announced that it has successfully demonstrated end ...

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

Andelyn Biosciences and PQP Group have partnered to streamline cell and gene therapy supply to the EU and UK, integrating ...

Biohub's Virtual Biology Initiative now includes Google DeepMind, Isomorphic Labs, Meta, the DOE and NIH. Here is what the $1 ...

Cell line development is a critical step in establishing a robust foundation for biologics manufacturing. In our latest on-demand Expert Insights video, Sebastian Schwamb, our Senior Director Process ...

Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and its joint venture partner Austrianova, today announced the first ...